SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,170.53 |
| Enterprise Value ($M) | 2,265.56 |
| Book Value ($M) | 164.22 |
| Book Value / Share | 1.31 |
| Price / Book | 13.22 |
| NCAV ($M) | 84.65 |
| NCAV / Share | 0.67 |
| Price / NCAV | 25.64 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.84 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.55 |
| Current Ratio | 4.08 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 727.72 |
| Assets | 807.28 |
| Liabilities | 643.07 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 781.37 |
| Operating Income | -164.98 |
| Net Income | -197.88 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -87.87 |
| Cash from Investing | -0.40 |
| Cash from Financing | 149.24 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 4.50 | -9.58 | |
| 13G/A | Wellington Management Group Llp | 9.50 | -24.14 | |
| 13G | Morgan Stanley | 7.70 | ||
| 13G/A | Deep Track Capital, LP | 4.82 | ||
| 13G/A | T. Rowe Price Investment Management, Inc. | 2.50 | -52.64 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 286,175 | 1,915,977 | 14.94 | |
| 496,881 | 2,616,587 | 18.99 | |
| 568,099 | 2,570,574 | 22.10 | |
| 489,462 | 2,758,572 | 17.74 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AMRX – Amneal Pharmaceuticals, Inc. | ANAB – AnaptysBio, Inc. |
| ANNX – Annexon, Inc. | ARQT – Arcutis Biotherapeutics, Inc. |
| ARVN – Arvinas, Inc. |
Financial data and stock pages provided by
Fintel.io